US Stock MarketDetailed Quotes
HUMA Humacyte
- 3.700
- 0.0000.00%
Close Apr 22 16:00 ET
- 3.770
- +0.070+1.89%
Pre 05:25 ET
440.61MMarket Cap-3457P/E (TTM)
3.900High3.300Low2.62MVolume3.900Open3.700Pre Close9.41MTurnover3.21%Turnover RatioLossP/E (Static)119.08MShares5.60052wk High32.46P/B302.07MFloat Cap1.96052wk Low--Dividend TTM81.64MShs Float17.450Historical High--Div YieldTTM16.22%Amplitude0.000Historical Low3.592Avg Price1Lot Size
Humacyte Stock Forum
Sign in to post a comment
$Humacyte(HUMA.US$ Senator Tommy Tuberville filed 8 security purchases, including small biotech company Humacyte (HUMA) which has been testing to repair injuries in Ukraine.
1
2
Watching for answer
$Humacyte(HUMA.US$ Humacyte Announces FDA Has Accepted And Granted For Priority Review The Company's Biologics License Application Seeking Approval Of Human Acellular Vessel
8/23 watchlist ⚡️
$Apellis Pharmaceuticals(APLS.US$$Canadian Solar(CSIQ.US$$Foot Locker(FL.US$$Fulcrum Therapeutics(FULC.US$$AMTD Digital(HKD.US$$Heliogen(HLGN.US$$MicroCloud Hologram(HOLO.US$$Humacyte(HUMA.US$$Intuit(INTU.US$$JE Cleantech Holdings Limited(JCSE.US$$Morgan Stanley(MS.US$$Napco Security Technologies(NSSC.US$$Science Applications International(SAIC.US$$Top Financial Group(TOP.US$$Urban Outfitters(URBN.US$$VinFast Auto(VFS.US$
3
3
ColumnsToday's Pre-Market Stock Movers: AVGO, RKLB, LULU, XOM and More
Gapping up
In reaction to earnings/guidance:
• $HashiCorp(HCP.US$ +16.8%,$Lululemon Athletica(LULU.US$ +9.7%,$PagerDuty(PD.US$ +5%,$nCino(NCNO.US$ +3.8% (also Bank Operating System selected by Rabobank Australia and New Zealand),$Broadcom(AVGO.US$ +2.1%
Other news:
• $Ooma(OOMA.US$ +3.5% (acquires Junction Networks also reports earnings)
• $Momentus(MNTS.US$ +3.5% (files for $200 mln mixed securities shelf offering)
• $Humacyte(HUMA.US$ +2.9% (fi...
In reaction to earnings/guidance:
• $HashiCorp(HCP.US$ +16.8%,$Lululemon Athletica(LULU.US$ +9.7%,$PagerDuty(PD.US$ +5%,$nCino(NCNO.US$ +3.8% (also Bank Operating System selected by Rabobank Australia and New Zealand),$Broadcom(AVGO.US$ +2.1%
Other news:
• $Ooma(OOMA.US$ +3.5% (acquires Junction Networks also reports earnings)
• $Momentus(MNTS.US$ +3.5% (files for $200 mln mixed securities shelf offering)
• $Humacyte(HUMA.US$ +2.9% (fi...
13
ColumnsToday's pre-market stock movers: WMT, AMZN, KO, BABA and more
Gainers:
In reaction to earnings/guidance:
$Liberty Energy(LBRT.US$ +11.6%, $F5 Inc(FFIV.US$ +6.9%, $Encore Wire(WIRE.US$ + 5.6%, $Archer Daniels Midland(ADM.US$ +5.5%, $Bank of N.T Butterfield & Son(NTB.US$ +5%, $Albany International(AIN.US$ +5%, $3M(MMM.US$ +4.0%,
Other news:
$Shell Midstream(SHLX.US$ +10% (Shell USA to acquire all units in SHLX held by public at $15.85/unit total value $1.96 bln)
$BridgeBio Pharma(BBIO.US$...
In reaction to earnings/guidance:
$Liberty Energy(LBRT.US$ +11.6%, $F5 Inc(FFIV.US$ +6.9%, $Encore Wire(WIRE.US$ + 5.6%, $Archer Daniels Midland(ADM.US$ +5.5%, $Bank of N.T Butterfield & Son(NTB.US$ +5%, $Albany International(AIN.US$ +5%, $3M(MMM.US$ +4.0%,
Other news:
$Shell Midstream(SHLX.US$ +10% (Shell USA to acquire all units in SHLX held by public at $15.85/unit total value $1.96 bln)
$BridgeBio Pharma(BBIO.US$...
13
3
ColumnsTop upgrades and downgrades on 5/16
Upgrades
• $Alibaba(BABA.US$ : JPMorgan Upgrades to Overweight from Underweight - PT $130 (from $75)
• $KE Holdings(BEKE.US$ : JPMorgan Upgrades to Neutral from Underweight - PT $13.50 (from $7.50)
• $Baidu(BIDU.US$ : JPMorgan Upgrades to Neutral from Underweight - PT $125 (from $90)
• $Bilibili(BILI.US$ : JPMorgan Upgrades to Neutral from Underweight - PT $19 (from $15)
• $Baozun(BZUN.US$ : JPMorgan Upgrades to Neutral from Underweight - PT $8 (from...
• $Alibaba(BABA.US$ : JPMorgan Upgrades to Overweight from Underweight - PT $130 (from $75)
• $KE Holdings(BEKE.US$ : JPMorgan Upgrades to Neutral from Underweight - PT $13.50 (from $7.50)
• $Baidu(BIDU.US$ : JPMorgan Upgrades to Neutral from Underweight - PT $125 (from $90)
• $Bilibili(BILI.US$ : JPMorgan Upgrades to Neutral from Underweight - PT $19 (from $15)
• $Baozun(BZUN.US$ : JPMorgan Upgrades to Neutral from Underweight - PT $8 (from...
24
9
$Humacyte(HUMA.US$ Asns 3mil ion Float could explode with some attention ape stock shorts attacking.
Analyst Suraj Kalia initiated a $buy rating on $Humacyte(HUMA.US$ with a $16 price target.
Analysts believe Humacyte has pioneered a type of blood vessel with human cells for transplantation, and see commercial opportunities for the company in dialysis and vascular trauma markets. It has also offered a "call option" on type 1 diabetes, which could alter existing treatment paradigms.
Analysts believe Humacyte has pioneered a type of blood vessel with human cells for transplantation, and see commercial opportunities for the company in dialysis and vascular trauma markets. It has also offered a "call option" on type 1 diabetes, which could alter existing treatment paradigms.
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Ben Buttons : sounds like they're going to get alot of business for awhile which means more $ especially for politicians.
10baggerbammOP Ben Buttons: corrupt politicians